APO Research
Talk to an analyst

APO RESEARCH · REPORT

Melanocyte Protein PMEL

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Melanocyte Protein PMEL Industry Growth and Trends Forecast to 2032

19 December 202598 pages

Choose your research edition.

Industry ResearchMelanocyte Protein PMEL Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Melanocyte Protein PMEL Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Melanocyte Protein PMEL Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melanocyte Protein PMEL Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Melanocyte Protein PMEL Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Melanocyte Protein PMEL market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Melanocyte Protein PMEL include Vault Pharma Inc., Scancell Holdings Plc, Immunomic Therapeutics, Inc., ImmunoCellular Therapeutics, Ltd. and Antigen Express, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Melanocyte Protein PMEL market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Melanocyte Protein PMEL market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Melanocyte Protein PMEL market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Melanocyte Protein PMEL.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Melanocyte Protein PMEL market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Melanocyte Protein PMEL Market by Company

Vault Pharma Inc.

Scancell Holdings Plc

Immunomic Therapeutics, Inc.

ImmunoCellular Therapeutics, Ltd.

Antigen Express, Inc.

Melanocyte Protein PMEL Segment by Type

VPI-121

SCIB-1

AE-M vaccine

Others

Melanocyte Protein PMEL Segment by Application

Metastatic Melanoma

Melanoma

Glioblastoma Multiforme

Melanocyte Protein PMEL Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanocyte Protein PMEL market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melanocyte Protein PMEL and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanocyte Protein PMEL.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Melanocyte Protein PMEL manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Melanocyte Protein PMEL in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of VPI-121 Table 2. Major Company of SCIB-1 Table 3. Major Company of AE-M vaccine Table 4. Major Company of Others Table 5. Global Melanocyte Protein PMEL Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 7. Global Melanocyte Protein PMEL Sales Market Share in Volume by Type (2021-2026) Table 8. Global Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 9. Global Melanocyte Protein PMEL Sales Market Share in Value by Type (2021-2026) Table 10. Global Melanocyte Protein PMEL Price by Type (2021-2026) & (US$/Unit) Table 11. Global Melanocyte Protein PMEL Sales by Type (2027-2032) & (K Units) Table 12. Global Melanocyte Protein PMEL Sales Market Share in Volume by Type (2027-2032) Table 13. Global Melanocyte Protein PMEL Sales by Type (2027-2032) & (US$ Million) Table 14. Global Melanocyte Protein PMEL Sales Market Share in Value by Type (2027-2032) Table 15. Global Melanocyte Protein PMEL Price by Type (2027-2032) & (US$/Unit) Table 16. North America Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 17. North America Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 19. Europe Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 23. Latin America Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Melanocyte Protein PMEL Sales by Type (2021-2026) & (US$ Million) Table 26. Melanocyte Protein PMEL Industry Trends Table 27. Melanocyte Protein PMEL Industry Drivers Table 28. Melanocyte Protein PMEL Industry Opportunities and Challenges Table 29. Melanocyte Protein PMEL Industry Restraints Table 30. Global Melanocyte Protein PMEL Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Melanocyte Protein PMEL Revenue Market Share by Company (2021-2026) Table 32. Global Melanocyte Protein PMEL Sales by Company (2021-2026) & (K Units) Table 33. Global Melanocyte Protein PMEL Sales Share by Company (2021-2026) Table 34. Global Melanocyte Protein PMEL Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Melanocyte Protein PMEL Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Melanocyte Protein PMEL Major Company Production Sites and Headquarters Table 37. Global Melanocyte Protein PMEL Company, Product Type & Application Table 38. Global Melanocyte Protein PMEL Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Melanocyte Protein PMEL by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Melanocyte Protein PMEL Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Melanocyte Protein PMEL Sales by Region (2021-2026) & (K Units) Table 43. Global Melanocyte Protein PMEL Sales Market Share in Volume by Region (2021-2026) Table 44. Global Melanocyte Protein PMEL Sales by Region (2021-2026) & (US$ Million) Table 45. Global Melanocyte Protein PMEL Sales Market Share in Value by Region (2021-2026) Table 46. Global Melanocyte Protein PMEL Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Melanocyte Protein PMEL Sales by Region (2027-2032) & (K Units) Table 48. Global Melanocyte Protein PMEL Sales Market Share in Volume by Region (2027-2032) Table 49. Global Melanocyte Protein PMEL Sales by Region (2027-2032) & (US$ Million) Table 50. Global Melanocyte Protein PMEL Sales Market Share in Value by Region (2027-2032) Table 51. Global Melanocyte Protein PMEL Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Melanocyte Protein PMEL Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 54. Global Melanocyte Protein PMEL Sales Market Share in Volume by Application (2021-2026) Table 55. Global Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 56. Global Melanocyte Protein PMEL Sales Market Share in Value by Application (2021-2026) Table 57. Global Melanocyte Protein PMEL Price by Application (2021-2026) & (US$/Unit) Table 58. Global Melanocyte Protein PMEL Sales by Application (2027-2032) & (K Units) Table 59. Global Melanocyte Protein PMEL Sales Market Share in Volume by Application (2027-2032) Table 60. Global Melanocyte Protein PMEL Sales by Application (2027-2032) & (US$ Million) Table 61. Global Melanocyte Protein PMEL Sales Market Share in Value by Application (2027-2032) Table 62. Global Melanocyte Protein PMEL Price by Application (2027-2032) & (US$/Unit) Table 63. North America Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 64. North America Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 66. Europe Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 70. Latin America Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Melanocyte Protein PMEL Sales by Application (2021-2026) & (US$ Million) Table 73. Vault Pharma Inc. Company Information Table 74. Vault Pharma Inc. Business Overview Table 75. Vault Pharma Inc. Melanocyte Protein PMEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Vault Pharma Inc. Melanocyte Protein PMEL Product Portfolio Table 77. Vault Pharma Inc. Recent Development Table 78. Scancell Holdings Plc Company Information Table 79. Scancell Holdings Plc Business Overview Table 80. Scancell Holdings Plc Melanocyte Protein PMEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Scancell Holdings Plc Melanocyte Protein PMEL Product Portfolio Table 82. Scancell Holdings Plc Recent Development Table 83. Immunomic Therapeutics, Inc. Company Information Table 84. Immunomic Therapeutics, Inc. Business Overview Table 85. Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Product Portfolio Table 87. Immunomic Therapeutics, Inc. Recent Development Table 88. ImmunoCellular Therapeutics, Ltd. Company Information Table 89. ImmunoCellular Therapeutics, Ltd. Business Overview Table 90. ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Product Portfolio Table 92. ImmunoCellular Therapeutics, Ltd. Recent Development Table 93. Antigen Express, Inc. Company Information Table 94. Antigen Express, Inc. Business Overview Table 95. Antigen Express, Inc. Melanocyte Protein PMEL Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Antigen Express, Inc. Melanocyte Protein PMEL Product Portfolio Table 97. Antigen Express, Inc. Recent Development Table 98. North America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 100. North America Melanocyte Protein PMEL Sales Market Share by Country (2021-2026) Table 101. North America Melanocyte Protein PMEL Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Melanocyte Protein PMEL Sales Market Share Forecast by Country (2027-2032) Table 103. North America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Melanocyte Protein PMEL Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Melanocyte Protein PMEL Market Share by Country (2021-2026) Table 106. North America Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Melanocyte Protein PMEL Market Share Forecast by Country (2027-2032) Table 108. Europe Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 110. Europe Melanocyte Protein PMEL Sales Market Share by Country (2021-2026) Table 111. Europe Melanocyte Protein PMEL Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Melanocyte Protein PMEL Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Melanocyte Protein PMEL Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Melanocyte Protein PMEL Market Share by Country (2021-2026) Table 116. Europe Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Melanocyte Protein PMEL Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Melanocyte Protein PMEL Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Melanocyte Protein PMEL Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Melanocyte Protein PMEL Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Melanocyte Protein PMEL Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Melanocyte Protein PMEL Market Share by Country (2021-2026) Table 126. Asia-Pacific Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Melanocyte Protein PMEL Market Share Forecast by Country (2027-2032) Table 128. Latin America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 130. Latin America Melanocyte Protein PMEL Sales Market Share by Country (2021-2026) Table 131. Latin America Melanocyte Protein PMEL Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Melanocyte Protein PMEL Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Melanocyte Protein PMEL Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Melanocyte Protein PMEL Market Share by Country (2021-2026) Table 136. Latin America Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Melanocyte Protein PMEL Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Melanocyte Protein PMEL Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Melanocyte Protein PMEL Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Melanocyte Protein PMEL Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Melanocyte Protein PMEL Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Melanocyte Protein PMEL Market Share by Country (2021-2026) Table 146. Middle East and Africa Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Melanocyte Protein PMEL Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Melanocyte Protein PMEL Distributors List Table 151. Melanocyte Protein PMEL Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Melanocyte Protein PMEL Image Figure 2. Global Melanocyte Protein PMEL Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melanocyte Protein PMEL Market Size (2021-2032) & (US$ Million) Figure 4. Global Melanocyte Protein PMEL Sales (2021-2032) & (K Units) Figure 5. VPI-121 Image Figure 6. Global VPI-121 Sales YoY Growth (2021-2032) & (K Units) Figure 7. SCIB-1 Image Figure 8. Global SCIB-1 Sales YoY Growth (2021-2032) & (K Units) Figure 9. AE-M vaccine Image Figure 10. Global AE-M vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Melanocyte Protein PMEL Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Melanocyte Protein PMEL Market Share by Type 2025 VS 2032 Figure 15. North America Melanocyte Protein PMEL Sales Market Share in Volume by Type in 2025 Figure 16. North America Melanocyte Protein PMEL Sales Market Share in Value by Type in 2025 Figure 17. Europe Melanocyte Protein PMEL Sales Market Share in Volume by Type in 2025 Figure 18. Europe Melanocyte Protein PMEL Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Melanocyte Protein PMEL Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Melanocyte Protein PMEL Sales Market Share in Value by Type in 2025 Figure 21. Latin America Melanocyte Protein PMEL Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Melanocyte Protein PMEL Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Melanocyte Protein PMEL Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Melanocyte Protein PMEL Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Melanocyte Protein PMEL Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Metastatic Melanoma Image Figure 28. Global Metastatic Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Melanoma Image Figure 30. Global Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Glioblastoma Multiforme Image Figure 32. Global Glioblastoma Multiforme Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Melanocyte Protein PMEL Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Melanocyte Protein PMEL Market Share by Application 2025 VS 2032 Figure 35. North America Melanocyte Protein PMEL Sales Market Share in Volume by Application in 2025 Figure 36. North America Melanocyte Protein PMEL Sales Market Share in Value by Application in 2025 Figure 37. Europe Melanocyte Protein PMEL Sales Market Share in Volume by Application in 2025 Figure 38. Europe Melanocyte Protein PMEL Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Melanocyte Protein PMEL Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Melanocyte Protein PMEL Sales Market Share in Value by Application in 2025 Figure 41. Latin America Melanocyte Protein PMEL Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Melanocyte Protein PMEL Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Melanocyte Protein PMEL Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Melanocyte Protein PMEL Sales Market Share in Value by Application in 2025 Figure 45. North America Melanocyte Protein PMEL Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Melanocyte Protein PMEL Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Melanocyte Protein PMEL Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Melanocyte Protein PMEL Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Melanocyte Protein PMEL Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Melanocyte Protein PMEL Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Melanocyte Protein PMEL Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Melanocyte Protein PMEL Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Melanocyte Protein PMEL Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Melanocyte Protein PMEL Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Melanocyte Protein PMEL Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Melanocyte Protein PMEL Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Melanocyte Protein PMEL Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Melanocyte Protein PMEL Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Melanocyte Protein PMEL Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Melanocyte Protein PMEL Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Melanocyte Protein PMEL Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Melanocyte Protein PMEL Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • VPI-121
  • SCIB-1
  • AE-M vaccine
  • Others
Applications
  • Metastatic Melanoma
  • Melanoma
  • Glioblastoma Multiforme
Companies covered
  • Vault Pharma Inc.
  • Scancell Holdings Plc
  • Immunomic Therapeutics, Inc.
  • ImmunoCellular Therapeutics, Ltd.
  • Antigen Express, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Melanocyte Protein PMEL Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Melanocyte Protein PMEL Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Melanocyte Protein PMEL Market by Type
  6. 1.3.1 VPI-121
  7. 1.3.2 SCIB-1
  8. 1.3.3 AE-M vaccine
  9. 1.3.4 Others
  10. 1.4 Global Melanocyte Protein PMEL Market Size by Type
  11. 1.4.1 Global Melanocyte Protein PMEL Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Melanocyte Protein PMEL Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Melanocyte Protein PMEL Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Melanocyte Protein PMEL Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Melanocyte Protein PMEL Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Melanocyte Protein PMEL Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Melanocyte Protein PMEL Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Melanocyte Protein PMEL Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Melanocyte Protein PMEL Industry Trends
  2. 2.2 Melanocyte Protein PMEL Industry Drivers
  3. 2.3 Melanocyte Protein PMEL Industry Opportunities and Challenges
  4. 2.4 Melanocyte Protein PMEL Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Melanocyte Protein PMEL Revenue (2021-2026)
  2. 3.2 Global Top Players by Melanocyte Protein PMEL Sales (2021-2026)
  3. 3.3 Global Top Players by Melanocyte Protein PMEL Price (2021-2026)
  4. 3.4 Global Melanocyte Protein PMEL Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Melanocyte Protein PMEL Major Company Production Sites & Headquarters
  6. 3.6 Global Melanocyte Protein PMEL Company, Product Type & Application
  7. 3.7 Global Melanocyte Protein PMEL Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Melanocyte Protein PMEL Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Melanocyte Protein PMEL Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Melanocyte Protein PMEL Tier 1, Tier 2, and Tier 3
4 Melanocyte Protein PMEL Regional Status and Outlook
  1. 4.1 Global Melanocyte Protein PMEL Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Melanocyte Protein PMEL Historic Market Size by Region
  3. 4.2.1 Global Melanocyte Protein PMEL Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Melanocyte Protein PMEL Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Melanocyte Protein PMEL Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Melanocyte Protein PMEL Forecasted Market Size by Region
  7. 4.3.1 Global Melanocyte Protein PMEL Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Melanocyte Protein PMEL Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Melanocyte Protein PMEL Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Melanocyte Protein PMEL by Application
  1. 5.1 Melanocyte Protein PMEL Market by Application
  2. 5.1.1 Metastatic Melanoma
  3. 5.1.2 Melanoma
  4. 5.1.3 Glioblastoma Multiforme
  5. 5.2 Global Melanocyte Protein PMEL Market Size by Application
  6. 5.2.1 Global Melanocyte Protein PMEL Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Melanocyte Protein PMEL Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Melanocyte Protein PMEL Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Melanocyte Protein PMEL Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Melanocyte Protein PMEL Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Melanocyte Protein PMEL Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Melanocyte Protein PMEL Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Melanocyte Protein PMEL Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Vault Pharma Inc.
  2. 6.1.1 Vault Pharma Inc. Company Information
  3. 6.1.2 Vault Pharma Inc. Business Overview
  4. 6.1.3 Vault Pharma Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Vault Pharma Inc. Melanocyte Protein PMEL Product Portfolio
  6. 6.1.5 Vault Pharma Inc. Recent Developments
  7. 6.2 Scancell Holdings Plc
  8. 6.2.1 Scancell Holdings Plc Company Information
  9. 6.2.2 Scancell Holdings Plc Business Overview
  10. 6.2.3 Scancell Holdings Plc Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Scancell Holdings Plc Melanocyte Protein PMEL Product Portfolio
  12. 6.2.5 Scancell Holdings Plc Recent Developments
  13. 6.3 Immunomic Therapeutics, Inc.
  14. 6.3.1 Immunomic Therapeutics, Inc. Company Information
  15. 6.3.2 Immunomic Therapeutics, Inc. Business Overview
  16. 6.3.3 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Product Portfolio
  18. 6.3.5 Immunomic Therapeutics, Inc. Recent Developments
  19. 6.4 ImmunoCellular Therapeutics, Ltd.
  20. 6.4.1 ImmunoCellular Therapeutics, Ltd. Company Information
  21. 6.4.2 ImmunoCellular Therapeutics, Ltd. Business Overview
  22. 6.4.3 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Product Portfolio
  24. 6.4.5 ImmunoCellular Therapeutics, Ltd. Recent Developments
  25. 6.5 Antigen Express, Inc.
  26. 6.5.1 Antigen Express, Inc. Company Information
  27. 6.5.2 Antigen Express, Inc. Business Overview
  28. 6.5.3 Antigen Express, Inc. Melanocyte Protein PMEL Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Antigen Express, Inc. Melanocyte Protein PMEL Product Portfolio
  30. 6.5.5 Antigen Express, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Melanocyte Protein PMEL Sales by Country
  2. 7.1.1 North America Melanocyte Protein PMEL Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Melanocyte Protein PMEL Sales by Country (2021-2026)
  4. 7.1.3 North America Melanocyte Protein PMEL Sales Forecast by Country (2027-2032)
  5. 7.2 North America Melanocyte Protein PMEL Market Size by Country
  6. 7.2.1 North America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Melanocyte Protein PMEL Market Size by Country (2021-2026)
  8. 7.2.3 North America Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Melanocyte Protein PMEL Sales by Country
  2. 8.1.1 Europe Melanocyte Protein PMEL Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Melanocyte Protein PMEL Sales by Country (2021-2026)
  4. 8.1.3 Europe Melanocyte Protein PMEL Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Melanocyte Protein PMEL Market Size by Country
  6. 8.2.1 Europe Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Melanocyte Protein PMEL Market Size by Country (2021-2026)
  8. 8.2.3 Europe Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Melanocyte Protein PMEL Sales by Country
  2. 9.1.1 Asia-Pacific Melanocyte Protein PMEL Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Melanocyte Protein PMEL Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Melanocyte Protein PMEL Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Melanocyte Protein PMEL Market Size by Country
  6. 9.2.1 Asia-Pacific Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Melanocyte Protein PMEL Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Melanocyte Protein PMEL Sales by Country
  2. 10.1.1 South America Melanocyte Protein PMEL Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Melanocyte Protein PMEL Sales by Country (2021-2026)
  4. 10.1.3 South America Melanocyte Protein PMEL Sales Forecast by Country (2027-2032)
  5. 10.2 South America Melanocyte Protein PMEL Market Size by Country
  6. 10.2.1 South America Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Melanocyte Protein PMEL Market Size by Country (2021-2026)
  8. 10.2.3 South America Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Melanocyte Protein PMEL Sales by Country
  2. 11.1.1 Middle East and Africa Melanocyte Protein PMEL Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Melanocyte Protein PMEL Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Melanocyte Protein PMEL Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Melanocyte Protein PMEL Market Size by Country
  6. 11.2.1 Middle East and Africa Melanocyte Protein PMEL Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Melanocyte Protein PMEL Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Melanocyte Protein PMEL Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Melanocyte Protein PMEL Value Chain Analysis
  2. 12.1.1 Melanocyte Protein PMEL Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Melanocyte Protein PMEL Production Mode & Process
  7. 12.2 Melanocyte Protein PMEL Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Melanocyte Protein PMEL Distributors
  10. 12.2.3 Melanocyte Protein PMEL Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst